Plaisier et al. (2016) [143] developed the TF-target gene interaction database and the Systems Genetics Network Analysis (SYGNAL) pipeline (Table 1), for dissecting GBM-related causal transcriptional regulatory networks (TRNs) and predicting drug targets, based on multi-omics and clinical patient data. This evidence concerns the gene TF and glioblastoma.